Campbell Wilson
Director/Board Member chez Pharmaceutical Licensing Group Ltd.
Profil
Campbell Wilson is currently a Director at Pharmaceutical Licensing Group Ltd.
and a Director at Tarsis Technology Ltd.
He previously worked as a Director-Executive Business Development at AstraZeneca PLC and as an Independent Non-Executive Director at Frontier IP Group Plc from 2014 to 2023.
Postes actifs de Campbell Wilson
| Sociétés | Poste | Début |
|---|---|---|
| Pharmaceutical Licensing Group Ltd. | Director/Board Member | - |
Tarsis Technology Ltd.
 Tarsis Technology Ltd. Packaged SoftwareTechnology Services Tarsis Technology Ltd. engages in research and experimental development on natural sciences and engineering. The company was founded on December 6, 2016 and is headquartered in London, the United Kingdom. | Director/Board Member | 06/12/2016 |
Anciens postes connus de Campbell Wilson
| Sociétés | Poste | Fin |
|---|---|---|
| FRONTIER IP GROUP PLC | Director/Board Member | 21/04/2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| FRONTIER IP GROUP PLC | Commercial Services |
| Entreprise privées | 2 |
|---|---|
| Pharmaceutical Licensing Group Ltd. | |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Tarsis Technology Ltd. engages in research and experimental development on natural sciences and engineering. The company was founded on December 6, 2016 and is headquartered in London, the United Kingdom. | Technology Services |
